Short Talk: The Next Generation Diarylquinoline TBAJ 587 has Superior Efficacy Against, and Restricts Selection of, Bedaquiline Resistant Rv0678 Mutants in a Mouse Model of Tuberculosis

Date

October 4, 2020

Speaker

Paul J. Converse, PhD

Johns Hopkins University

Tracks

Rethinking Risk in TB

Related Products

Thumbnail for Short Talk: The Next Generation Diarylquinoline TBAJ 587 has Superior Efficacy Against, and Restricts Selection of, Bedaquiline Resistant Rv0678 Mutants in a Mouse Model of Tuberculosis

Short Talk: The Next Generation Diarylquinoline TBAJ 587 has Superior Efficacy Against, and Restricts Selection of, Bedaquiline Resistant Rv0678 Mutants in a Mouse Model of Tuberculosis

Thumbnail for Short Talk: The Effect of Dysglycemia on Mycobacterium tuberculosis Transmission to Close Contacts of Persons with Pulmonary Tuberculosis

Short Talk: The Effect of Dysglycemia on Mycobacterium tuberculosis Transmission to Close Contacts of Persons with Pulmonary Tuberculosis

Thumbnail for Short Talk: Integration of Genetic and Transcriptional Profiles of Innate Cells to Decipher Mechanisms of TB Susceptibility

Short Talk: Integration of Genetic and Transcriptional Profiles of Innate Cells to Decipher Mechanisms of TB Susceptibility

Thumbnail for Short Talk: CryoEM Structure of an Mce/YrbE ABC Transporter Complex Sheds Light on Hydrophobic Transport across the Envelope

Short Talk: CryoEM Structure of an Mce/YrbE ABC Transporter Complex Sheds Light on Hydrophobic Transport across the Envelope

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.